Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial

Not Applicable

• Conditions: Circulatory System; Pregnancy and Childbirth; Hypertensive disorders in pregnancy, pregnancy-induced hypertension, preeclampsia

• Registration Number: PACTR201311000700893
• Lead Sponsor: niversity Medical Center Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-08
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 440

Inclusion Criteria

<16 weeks of gestation and over 18 years of age,
- Intention to have subsequent antenatal visits and delivery at the same clinic.
- Can receive text messages by phone or through the phone of a proxy.
- A moderate to high risk (>20%) of developing PIH

Exclusion Criteria

- Pre-existing hypertension or hypertension before 20 weeks gestation.
- Likely non-compliance with the protocol in view of the treating physician
- Comorbidity interfering with the protocol
- Known contraindications to Investigational Product components

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnancy-induced hypertension

Secondary Outcome Measures

Name	Time	Method
eonatal and infant outcomes: preterm birth, Intra uterine death, stillbirth, neonatal mortality, congenitial abnormality, NICU admission or pediatrician referral, birth weight, small for gestational age, apgar scores, other adverse effects. Infant outcomes: weight and hight, health, occurrence of disease and general health status. ;Tertiary: uptake and tolerability;Maternal/obstetric outcomes: maternal death, preeclampsia, eclampsia, HELLP syndrome, hemorrhage, saesarian section, other complications during pregnancy or delivery